BacAlt Biosciences: Pioneering Biopolymers for Sustainable Products in 2026
Discover how BacAlt Biosciences is revolutionizing sustainable products with biopolymers in 2026, offering eco-friendly alternatives to synthetic additives.
LazyFounders
30 SEC SUMMARY
BacAlt Biosciences, founded in 2023, aims to provide sustainable alternatives to synthetic polymers using biopolymers derived from agricultural waste. With a funding of ₹18 crore in 2025, the company seeks to revolutionize personal care, home care, and other industries by offering cost-effective, biodegradable additives.
TABLE OF CONTENTS
COMPANY OVERVIEW
BacAlt Biosciences, founded in 2023 by Shruti Kutmutia and Pranav Nair, is based in Electronics City, Bengaluru. The company focuses on industrial biotechnology and specialty ingredients, aiming to replace synthetic polymers with biopolymers derived from agricultural waste.
THE INNOVATION: BIOPOLYMERS FROM WASTE
BacAlt's unique approach involves fermenting agricultural and agro-industrial waste to produce bacterial cellulose and poly-gamma glutamic acid. Unlike traditional methods that use sterile tanks, BacAlt's non-sterile fermentation process significantly reduces costs and energy consumption. This innovation allows BacAlt to offer a blend called ReRaw, which can replace up to five synthetic additives with a single biodegradable ingredient.
FUNDING AND INVESTORS
In September 2025, BacAlt Biosciences raised ₹18 crore (about $2 million), led by Avaana Capital, with participation from Lubrizol InnoVentures. This funding was intended for research and development, pilot-scale production, hiring, and expanding into new markets.
PRODUCTS AND APPLICATIONS
BacAlt's ReRaw blend is designed to replace synthetic polymers in personal care, oral care, and home care products. The company also targets agrochemicals, nutraceuticals, pharmaceuticals, textiles, and wound care markets. BacAlt's goal is to help India transition from importing to exporting specialty ingredients.
FUTURE PLANS AND CHALLENGES
Initially, BacAlt planned to launch its first commercial product in June 2026, followed by agrochemical and pharmaceutical markets in 2027. However, the launch date has passed, and no new product announcements have been made. The company continues to seek partnerships and expand its market reach.
KEY HIGHLIGHTS
- BacAlt Biosciences uses agricultural waste to produce biopolymers.
- The company raised ₹18 crore in funding in 2025.
- ReRaw blend aims to replace up to five synthetic additives.
- BacAlt targets multiple industries beyond personal care.
- The company seeks to transition India from importing to exporting specialty ingredients.
FAQs
What is BacAlt Biosciences?
BacAlt Biosciences is a biotech startup founded in 2023, focused on producing biopolymers from agricultural waste to replace synthetic additives in various industries.
What are the main products of BacAlt Biosciences?
The main products are bacterial cellulose and poly-gamma glutamic acid, combined into a blend called ReRaw.
What was the amount of funding raised by BacAlt Biosciences?
BacAlt Biosciences raised ₹18 crore (about $2 million) in funding in September 2025.
CONCLUSION
BacAlt Biosciences is at the forefront of developing sustainable alternatives to synthetic polymers. By leveraging agricultural waste and innovative fermentation techniques, the company aims to revolutionize various industries while addressing the microplastic pollution issue.
CALL-TO-ACTION
Learn more about sustainable innovations and how they can transform industries by visiting blogy.in.
Sources
This story is an original summary and analysis written by LazyFounders from the reporting listed above. Facts are attributed to their original publishers; sections marked as analysis are LazyFounders's opinion. Where a source is in another language, facts were machine-translated and quotations are reported, not reproduced. Read the original coverage via the links.
